Testimonials

Arresto Bioscience, Victoria Smith, Ph.D.

The complex Oncology models performed at Aragen BioScience have been invaluable in moving our monoclonal antibody therapeutic programs forward.  We are looking forward to continuing to use Aragen’s services as our pre-clinical program evolves.

Biolex, Dr. Lynn Dickey, Ph.D., VP of Research and Technology Development

We continue to depend upon Aragen’s cell based assay expertise, and feel as if we are all on the same research team.
See research paper co-authored with Biolex

Incode Pharmaceuticals, Bill St. John, C.E.O.

Aragen is the first CRO that has understood the complexity of our needs from both a technical and regulatory perspective.

Neumedicines Inc, Lena A. Basile, Ph.D., J.D., President

Our selection of Aragen to provide cell line development services was based on their solid track record of success in this field.  Moreover, our interactions with Aragen scientists and staff further assured us that our project was in the hands of highly qualified professionals who could get the “get the job done.”

PharmaDirections, Dr. Michelle Higgin, Biologics Development Manager

When presenting Aragen with our study plan, it was clear from our first discussion that they understood our needs.

Return Home